NDC 43598-262-11 - Fulvestrant
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43598-262
- Requested NDC
- 43598-262-11
- Package NDCs from labels
- 43598-262-11, 43598-262-02, 43598-262-23
- Manufacturer
- Dr.Reddy's Laboratories Inc | Dr.Reddy's Laboratories Limited-FTO-9
- Effective date
- 2025-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fulvestrant - Dr.Reddy's Laboratories Inc | Dr.Reddy's Laboratories Limited-FTO-9 | Dr.Reddy's Laboratories Inc | Dr.Reddy's Laboratories Limited-FTO-9 | 2025-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-262-02 | Fulvestrant | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 19 | |
| 43598-262-11 | Fulvestrant | 5 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 5 | 19 | |
| 43598-262-23 | Fulvestrant | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43598-262-02 | ML - Milliliter | 43598-262 | ffea5f6c-7731-4740-a3f9-edad8d056f49 | 1 | 2020-09-14 |
| 43598-262-11 | ML - Milliliter | 43598-262 | 03ff9a88-c9c3-4495-be64-9a6c0bc83841 | 1 | 2020-09-14 |
| 43598-262-23 | ML - Milliliter | 43598-262 | a0670a5a-4694-44ec-9686-8ad954149217 | 1 | 2024-10-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FULVESTRANT | FULVESTRANT | Zydus Lifesciences Limited | 151b948a-3106-497a-b1c7-479307faeb89 | 2022-08-26 | 727762 22X328QOC4 | |
| FULVESTRANT | FULVESTRANT | Xiromed, LLC | 840cd7c0-9f33-f74e-f136-de7fe899bfb4 | 2021-10-04 | Warnings, Adverse reactions | 727762 22X328QOC4 |
| FULVESTRANT | FULVESTRANT | Northstar Rx, LLC, | 67566681-19b5-89df-2030-25df5b0cf641 | 2021-08-23 | Warnings, Adverse reactions | 727762 22X328QOC4 |
| FASLODEX | FULVESTRANT | AstraZeneca Pharmaceuticals LP | 83d7a440-e904-4e36-afb5-cb02b1c919f7 | 2020-09-25 | Warnings, Adverse reactions | 727762 22X328QOC4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.